683 Capital Management »

Pyxis Oncology shares owned by 683 Capital Management

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 415k 3.67

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Insmed Note 0.750% 6/0 (Principal)
Wave Life Sciences SHS (WVE)
Alnylam Pharmaceuticals Put Option (ALNY)
Cogent Communications Hldgs Com New (CCOI)
Tg Therapeutics (TGTX)
BorgWarner (BWA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Viking Therapeutics (VKTX)

View all positions for 683 Capital Management

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
BlackRock
BlackRock
Balyasny Asset Management
Vanguard Group
Ikarian Capital
Blue Owl Capital Holdings
Geode Capital Management
Standard Life Aberdeen
Stempoint Capital
State Street Corporation
Perceptive Advisors
Superstring Capital Management
683 Capital Management

View all funds holding Pyxis Oncology